Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

ENETS Abstract Search

#4020 Ovarian neuroendocrine tumor metastases can induce estrogen production in postmenopausal patients

Introduction: Neuroendocrine tumors (NET) are malignant neoplasms that can be associated with specific hormonal syndromes.

Conference:

Presenting Author: Mulders M

Authors: Mulders M, Hofland J, de Herder W, van Velthuysen M, Roes E,

Keywords: ovary, neuroendocrine, tumor, estradiol, postmenopausal, bleeding,

#3375 Neuroendocrine tumors associated with ovarian teratoma – One centre experience

Introduction: Ovarian teratomas are frequent gynaecological finding in contrary to ovarian NETs which comprise only 0.1% of all ovarian neoplasms. In contrast to other gynaecological organs like cervix, endometrium vagina or vulva in which the common type of NENs is NECs, in case of ovarian carcinoid the prognosis remains good.

Conference:

Presenting Author: Opalinska M

Authors: Opalinska M, Sowa-Staszczak A, Olearskaa H, Ulatowska-Bialas M, Gilis-Januszewska A,

Keywords: ovarian carcinoid, NET, teratoma, outcome,

#3113 Small cell neuroendocrine carcinoma of vagina - Rare, aggressive but curable?

Introduction: Small cell neuroendocrine carcinoma (SCNC) is a highly proliferative disease. It commonly affects lung and only 2.5-5% are extrapulmonary. SCNC of vagina is very rare with only 32 published cases in English literature.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Godinho J, Simões P, Leal-Costa L, Baptista C, Casa-Nova M,

Keywords: small cell neuroendocrine carcinoma, vagina, highly proliferative, rare disease,

#2712 HORMONET: Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors (NET) and Hormone Receptor Positive Expression

Introduction: We have shown immunohistochemistry (IHC) expression of estrogen (ER) and progesterone receptors (PR) in 20.8% and 18.8% of 96 NET patients (pts). An old clinical trial (Mortel C, 1984) suggested antitumor effects of estrogen/progesterone-directed therapies in NET. Yet the effects of an antiestrogen agent in NET pts whose tumor express ER and/or PR are unknown.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Riechelmann R

Authors: Riechelmann R, Donadio M, Felismino T, Fonseca de Jesus V, Mello C,

Keywords: neuroendocrine, estrogen, progesterone, clinical trial,

#1055 Neuroendocrine Pancreatic Tumor Associated with a Cerebral Neurofibroma. A Case Report.

Introduction: Neuroendocrine pancreatic tumors (pNET) are rare in young patients. They usually occur in the setting of genetic syndromes.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Lico V

Authors: Moletta L, Milanetto A, Lico V, Farinati F, Alaggio R,

Keywords: pnet, cerebral neurofibroma, nf-1,